All In Biotech

Drug Trial Radar · NCT01779258

Emollients in the Management of Atopic Dermatitis

Emollients in the Management of Atopic Dermatitis in Children: Prevention of Flares.

Last checked: Nov 19, 2026Latest source record: Feb 19, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 347 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

347

Actual

Start

Feb 2013

Primary completion

Feb 2014

Study completion Feb 2014

Sponsor

Lead sponsor
Pierre Fabre MedicamentIndustry
Sponsor type
Industry
First posted
Jan 30, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to confirm that emollients play a major role in the maintenance therapy after clearing of inflammatory lesions and can reduce occurrence of flares in children with atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • glycerol, paraffin (liquid and white soft)Drug

    1 application in the morning and in the evening

  • Atopiclair®Device

    1 application in the morning, in the afternoon and in the evening

  • Locatop@Drug

    During the Run-In period: 1 application in the morning and in the evening during a maximum of 21 days

  • Locapred@Drug

    During the 3 months study treatment: 1 application in the evening in case of flare "

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of patients with at least one flare over the treatment periodTime frame: 12 weeks of treatment.

Locations

15 sites in 5 countries. Site status is shown where the registry gives one.

  • Site not named

    Tallinn, Estonia

  • Site not named

    Tartu, Estonia

  • Site not named

    Bordeaux, France

  • Site not named

    Poitiers, France

  • Site not named

    Vilnius, Lithuania

  • Site not named

    Lodz, Poland

  • Site not named

    Płock, Poland

  • Site not named

    Pruszków, Poland

  • Site not named

    Warsaw, Poland

  • Site not named

    Brasov, Romania

  • Site not named

    Bucharest, Romania

  • Site not named

    Craiova, Romania

  • Site not named

    Iași, Romania

  • Site not named

    Sibiu, Romania

  • Site not named

    Targu Mureş, Romania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.